Canagliflozin D4

CAS : 1997338-61-0

Ref. 3D-FC146109

Informations sur le produit

• Nom: Canagliflozin D4
• Marque: Biosynth
• Description: Canagliflozin D4 is a synthetic compound that inhibits the SGLT2 transporter and increases the renal excretion of glucose. Canagliflozin D4 is used in the treatment of type 2 diabetes mellitus and is marketed as Invokana. Canagliflozin D4 is a racemic mixture of two enantiomers, with (S)-canagliflozin being more potent than (R)-canagliflozin. The reaction monitoring technique was used to monitor the production of metformin from canagliflozin D4 by extraction with diethyl ether. A validated method for quantification and monitoring was developed using deuterated water for flow rate linearity optimization. This method was applied to plasma samples obtained from healthy Indian subjects who were administered canagliflozin D4 at variable doses over 24 hours. The pharmacokinetic parameters were determined for each subject, resulting in an optimization of this drug dose range.

Propriétés chimiques

• Masse moléculaire: 448.54 g/mol
• Formule: C₂₄H₂₁D₄FO₅S
• Degré de pureté: Min. 95%